Search results
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 2 days agoCytokinetics stock reversed higher Tuesday after safety worries clouded promising study results for...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance via AOL· 3 days agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings...
US FDA approves expanded use of Bristol Myers' cancer cell therapy (May 15)
AOL· 20 hours agoThe Food and Drug Administration's decision marks the fourth approval for Breyanzi, which can now be used to treat follicular lymphoma patients who have received two or more prior lines of therapy ...
Mindy Kaling said she'd like to retire in this Mass. vacation spot
Cape Cod Times via Yahoo News· 1 hour agoActress Mindy Kaling, a Cambridge native, said what her dream vacation spot in Massachusetts might...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 6 days agoIt's easy to find stocks that are lagging broader equities, even in a bull market like the one we're currently in. It's harder to find beaten-down stocks...
US FDA approves expanded use of Bristol’s cancer cell therapy
WHTC 1450 Holland· 20 hours ago(Reuters) -The U.S. health regulator said on Wednesday it has approved the expanded use of Bristol...
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 3 days agoBristol Myers Squibb’s (BMS) blockbuster cancer therapies Opdivo (nivolumab) and Yervoy (ipilimumab)...
Immunotherapy may boost survival after lung cancer surgery
United Press International via Yahoo News· 1 hour agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
The Motley Fool via AOL· 4 days agoAbout once every 90 days, publicly traded companies have to face their shareholders and let them...
Oxford BioDynamics, King's College London to Develop Biomarkers for Rheumatoid Arthritis Prevention
GenomeWeb News· 3 hours agoOxford BioDynamics said on Thursday that it is collaborating with King's College London to develop prognostic blood-based biomarkers to identify patients most likely to progress to rheumatoid ...